Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries
about
Gavi HPV Programs: Application to ImplementationImplementation science in cancer prevention and control: a framework for research and programs in low- and middle-income countriesCervical cancer prevention and treatment research in Africa: a systematic review from a public health perspectiveChallenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations.Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisEfficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries.Preparing for human papillomavirus vaccine introduction in Kenya: implications from focus-group and interview discussions with caregivers and opinion leaders in Western KenyaImmunoprevention of human papillomavirus-associated malignanciesCosting the supply chain for delivery of ACT and RDTs in the public sector in Benin and Kenya.Exploring the Potential Health Impact and Cost-Effectiveness of AIDS Vaccine within a Comprehensive HIV/AIDS Response in Low- and Middle-Income CountriesCost-effectiveness of HPV vaccination regime: comparing twice versus thrice vaccinations dose regime among adolescent girls in Malaysia.Estimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China.Oral Cholera Vaccination Delivery Cost in Low- and Middle-Income Countries: An Analysis Based on Systematic Review.Mothers' willingness to pay for HPV vaccines in Anambra state, Nigeria: a cross sectional contingent valuation study.Prevalence of Human Papilloma Virus Infection in Young Primiparous Women During Postpartum Period: Study from a Tertiary Care Center in Northern IndiaA cost comparison of introducing and delivering pneumococcal, rotavirus and human papillomavirus vaccines in Rwanda.Progress in HPV vaccination in low- and lower-middle-income countries.The health-economic studies of HPV vaccination in Southeast Asian countries: a systematic review.Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects.Cost effectiveness of human papilloma virus vaccination in low and middle income countries: a systematic review of literature.Maternal influenza immunization in Malawi: Piloting a maternal influenza immunization program costing tool by examining a prospective program.Cancer screening and prevention in low-resource settings.Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling study.Human papilloma virus: global research architecture assessed by density-equalizing mapping.
P2860
Q26783803-162A6B90-9202-493E-8363-50CB521FA1B4Q27013654-E126FD36-4D11-4F1D-B77A-0A11D8AC0EB6Q28601706-53B41993-1107-405F-A2CD-278B9ABAB861Q30245295-8083B8DF-E9FC-45FE-92C4-C8F7E8D3706AQ30386748-3FA26AB1-0242-4C61-865F-13CD4CCEF271Q30970916-E7DAB3FD-F8BE-41C9-999B-17AAE3CEB89FQ33757466-8F3B28CE-FB1D-4427-B40C-AF3419021F1CQ34151129-899B8C32-6E84-457D-8BF6-F922165CADA2Q35044376-E109A87D-C7AD-4390-BB19-B6A5A75E49ECQ35123707-F71EECDB-DFCD-49D3-B32A-62565F806061Q35885337-50DA711C-B7CE-4371-854E-B8A8614FCC37Q35902534-BD2251F8-5774-4647-8AFF-0D2419260E45Q36183172-5B12C44C-C1F0-4F1D-99FD-51C21BE54876Q36215966-83EDE0B1-BC87-47CF-8901-DB4E350037DDQ36976107-32C77447-56A7-4B74-B0CB-C39310B1A963Q37435623-C9C02CCD-E788-4A61-9733-C222A332D9D5Q37710495-2894B4D3-C263-4FF3-969D-17CB57582C7CQ39158741-F7B4F1C8-1047-4BAF-9882-135AF203367DQ39450074-40F68C9C-BFE2-4182-BFF7-FC46C75BD1ACQ42706838-5A73DE0E-3559-425E-B185-295C5C73C93DQ45324144-C2C79D23-6A86-41CA-A64E-9BF008DA9241Q48342158-D45F2943-1BC7-4F2A-BBDC-B1D640FA352AQ53253182-E00A7814-489F-4B24-B815-DCF327D50D18Q54233736-4F36A3D7-920F-48F3-ADD1-82D55D41C3DCQ55175761-D072AD57-B3BD-4F66-B2ED-7BBC4EEEABAB
P2860
Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Costs of introducing and deliv ...... ion grant support to countries
@ast
Costs of introducing and deliv ...... ion grant support to countries
@en
type
label
Costs of introducing and deliv ...... ion grant support to countries
@ast
Costs of introducing and deliv ...... ion grant support to countries
@en
prefLabel
Costs of introducing and deliv ...... ion grant support to countries
@ast
Costs of introducing and deliv ...... ion grant support to countries
@en
P2093
P2860
P1433
P1476
Costs of introducing and deliv ...... ion grant support to countries
@en
P2093
Carol Levin
Raymond Hutubessy
Susan A Wang
Vivien Tsu
P2860
P304
P356
10.1371/JOURNAL.PONE.0101114
P407
P577
2014-06-26T00:00:00Z